Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate
Over the past decades, researchers have reported several mechanisms for doxorubicin (DOX)-induced cardiomyopathy, including oxidative stress, inflammation, and apoptosis. Another mechanism that has been suggested is that DOX interferes with the cell cycle and induces oxidative stress in C-kit+ cells...
Saved in:
Main Authors: | Abdelrahman Ibrahim Abushouk (Author), Amr Muhammad Abdo Salem (Author), Anas Saad (Author), Ahmed M. Afifi (Author), Abdelrahman Yousry Afify (Author), Hesham Afify (Author), Hazem S.E. Salem (Author), Esraa Ghanem (Author), Mohamed M. Abdel-Daim (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenous Cardiac Stem Cell-Derived Exosomes Ameliorate Cardiac Dysfunction in Doxorubicin Induced Dilated Cardiomyopathy
by: Adam C. Vandergriff, et al.
Published: (2015) -
Trophoblast Stem-Cell-Derived Exosomes Improve Doxorubicin-Induced Dilated Cardiomyopathy by Modulating the let-7i/YAP Pathway
by: Jie Ni, et al.
Published: (2020) -
The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy
by: Xianyun Wang, et al.
Published: (2015) -
Physiological stress improves stem cell modeling of dystrophic cardiomyopathy
by: Dominic E. Fullenkamp, et al.
Published: (2024) -
Impact of nutrition counseling on anthropometry and dietary intake of multiple sclerosis patients at Kasr Alainy Multiple Sclerosis Unit, Cairo, Egypt 2019-2020: randomized controlled clinical trial
by: Zeinab Afifi, et al.
Published: (2023)